Treatment of proliferative diseases using an antisense IAP oligomer and chemotherapeutic agent

Details for Australian Patent Application No. 2004284855 (hide)

Owner Aegera Therapeutics, Inc.

Inventors Durkin, Jon P.; Lacasse, Eric; McManus, Daniel

Agent Spruson & Ferguson

Pub. Number AU-A-2004284855

PCT Pub. Number WO2005/042030

Priority 60/516,263 30.10.03 US

Filing date 29 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

8 June 2006 PCT application entered the National Phase

  PCT publication WO2005/042030 Priority application(s): WO2005/042030

16 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004284856-Device, especially tube or catheter, for at least partially introducing into a body passage

2004284851-A hygienic tampon and an absorbent body used in the formation of a tampon